A brief review of reporter gene imaging in oncolytic virotherapy and gene therapy by Susanna C. Concilio, Stephen J. Russell, Kah-Whye Peng

Get full text

Oncolytic varicella-zoster virus engineered with ORF8 deletion and armed with drug-controllable interleukin-12 by Stephen J Russell, Haifei Jiang, Rebecca Nace, Talia Fernandez Carrasco, Lianwen Zhang, Kah Whye Peng

Get full text

Oncolytic potency of HER-2 retargeted VSV-FH hybrid viruses: the role of receptor ligand affinity by Camilo Ayala Breton, Nitwara Wikan, Arinda Abbuhl, Duncan R Smith, Stephen J Russell, Kah-Whye Peng

Get full text

Reporter gene imaging identifies intratumoral infection voids as a critical barrier to systemic oncolytic virus efficacy by Amber Miller, Lukkana Suksanpaisan, Shruthi Naik, Rebecca Nace, Mark Federspiel, Kah Whye Peng, Stephen J Russell

Get full text

Long-term infection and vertical transmission of a gammaretrovirus in a foreign host species. by Toshie Sakuma, Jason M Tonne, Jessica A Malcolm, Tayaramma Thatava, Seiga Ohmine, Kah-Whye Peng, Yasuhiro Ikeda

Get full text

Dual-Isotope SPECT Imaging with NIS Reporter Gene and Duramycin to Visualize Tumor Susceptibility to Oncolytic Virus Infection by Lianwen Zhang, Lukkana Suksanpaisan, Huailei Jiang, Timothy R. DeGrado, Stephen J. Russell, Ming Zhao, Kah-Whye Peng

Get full text

Oncolytic virotherapy – Forging its place in the immunomodulatory paradigm for Multiple Myeloma by Joselle Cook, MD, Aldo A. Acosta-Medina, MD, Kah Whye Peng, PhD, Martha Lacy, MD, Stephen Russell, MD, PhD

Get full text

505 Relationship of infusion duration and dose to safety, efficacy and pharmacodynamics: second part of a phase 1–2 study using VSV-IFNβ-NIS (VV1) oncolytic virus in patients with... by Manish Patel, Melissa Johnson, James Strauss, Timothy Cripe, Erol Wiegert, Monica Reckner, Alice Bexon, Kah-Whye Peng, Stephen Russell, Luke Russell, Jaime Merchan

Surface-modified measles vaccines encoding oligomeric, prefusion-stabilized SARS-CoV-2 spike glycoproteins boost neutralizing antibody responses to Omicron and historical variants,... by Miguel Á. Muñoz-Alía, Rebecca A. Nace, Baskar Balakrishnan, Lianwen Zhang, Nandakumar Packiriswamy, Gagandeep Singh, Prajakta Warang, Ignacio Mena, Riya Narjari, Rianna Vandergaast, Kah-Whye Peng, Adolfo García-Sastre, Michael Schotsaert, Stephen J. Russell

Get full text

Enhancing the Oncolytic Activity of CD133-Targeted Measles Virus: Receptor Extension or Chimerism with Vesicular Stomatitis Virus Are Most Effective by Dina Kleinlützum, Dina Kleinlützum, Dina Kleinlützum, Julia D. S. Hanauer, Alexander Muik, Kay-Martin Hanschmann, Sarah-Katharina Kays, Camilo Ayala-Breton, Kah-Whye Peng, Michael D. Mühlebach, Tobias Abel, Christian J. Buchholz, Christian J. Buchholz

Get full text

Preclinical safety assessment of MV-s-NAP, a novel oncolytic measles virus strain armed with an H. pylori immunostimulatory bacterial transgene by Kimberly B. Viker, Michael B. Steele, Ianko D. Iankov, Susanna C. Concilio, Arun Ammayappan, Brad Bolon, Nathan J. Jenks, Matthew P. Goetz, Eleni Panagioti, Mark J. Federspiel, Minetta C. Liu, Kah Whye Peng, Evanthia Galanis

Get full text

Oncolytic Virus with Attributes of Vesicular Stomatitis Virus and Measles Virus in Hepatobiliary and Pancreatic Cancers by Bolni Marius Nagalo, Camilo Ayala Breton, Yumei Zhou, Mansi Arora, James M. Bogenberger, Oumar Barro, Michael B. Steele, Nathan J. Jenks, Alexander T. Baker, Dan G. Duda, Lewis Rowland Roberts, Stephen J. Russell, Kah Whye Peng, Mitesh J. Borad

Get full text

Preclinical Development of Oncolytic Immunovirotherapy for Treatment of HPVPOS Cancers by Lukkana Suksanpaisan, Rong Xu, Mulu Z. Tesfay, Carolyn Bomidi, Stefan Hamm, Rianna Vandergaast, Nathan Jenks, Michael B. Steele, Ayuko Ota-Setlik, Hinna Akhtar, Amara Luckay, Rebecca Nowak, Kah Whye Peng, John H. Eldridge, David K. Clarke, Stephen J. Russell, Rosa Maria Diaz

Get full text

422 Safety and efficacy of neoadjuvant intravesical oncolytic MV-NIS in patients with urothelial carcinoma by Paul Young, Erol Wiegert, Tanner Miest, Bradley Leibovich, Stephen Bardot, Stephen Boorjian, Mark Gonzalgo, Loren Herrera-Hernandez, Matthew Tollefson, Jeffrey Karnes, Paige Nichols, Tessa Kroeninger, Rachel Graham, Carole Lahana, Monica Reckner, Alysha Newsom, Nandakumar Packiriswamy, Janice Anoka, Kah Whye Peng, Alice Bexon, Shruthi Naik

Safety, pharmacokinetics, metabolism and radiation dosimetry of 18F-tetrafluoroborate (18F-TFB) in healthy human subjects by Huailei Jiang, Nicholas R. Schmit, Alex R. Koenen, Aditya Bansal, Mukesh K. Pandey, Robert B. Glynn, Bradley J. Kemp, Kera L. Delaney, Angela Dispenzieri, Jamie N. Bakkum-Gamez, Kah-Whye Peng, Stephen J. Russell, Tina M. Gunderson, Val J. Lowe, Timothy R. DeGrado

Get full text

CRISPR/Cas9‐mediated introduction of the sodium/iodide symporter gene enables noninvasive in vivo tracking of induced pluripotent stem cell‐derived cardiomyocytes by John W. Ostrominski, Ravi Chandra Yada, Noriko Sato, Michael Klein, Ksenia Blinova, Dakshesh Patel, Racquel Valadez, Maryknoll Palisoc, Stefania Pittaluga, Kah‐Whye Peng, Hong San, Yongshun Lin, Falguni Basuli, Xiang Zhang, Rolf E. Swenson, Mark Haigney, Peter L. Choyke, Jizhong Zou, Manfred Boehm, So Gun Hong, Cynthia E. Dunbar

Get full text

A phase I oncolytic virus trial with vesicular stomatitis virus expressing human interferon beta and tyrosinase related protein 1 administered intratumorally and intravenously in u... by Katherine E. R. Smith, Kah-Whye Peng, Jose S. Pulido, Adam J. Weisbrod, Carrie A. Strand, Jacob B. Allred, Alysha N. Newsom, Lianwen Zhang, Nandakumar Packiriswamy, Timothy Kottke, Jason M. Tonne, Madelyn Moore, Heather N. Montane, Lisa A. Kottschade, Robert R. McWilliams, Arkadiusz Z. Dudek, Yiyi Yan, Anastasios Dimou, Svetomir N. Markovic, Mark J. Federspiel, Richard G. Vile, Roxana S. Dronca, Matthew S. Block

Get full text